Specific targeting of atherosclerotic plaques in ApoE(-/-) mice using a new Camelid sdAb binding the vulnerable plaque marker LOX-1. (Q39218666)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Specific targeting of atherosclerotic plaques in ApoE(-/-) mice using a new Camelid sdAb binding the vulnerable plaque marker LOX-1.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

10 September 2017

Specific targeting of atherosclerotic plaques in ApoE(-/-) mice using a new Camelid sdAb binding the vulnerable plaque marker LOX-1. (English)

1 reference

Europe PubMed Central

10 September 2017

atherosclerosis

1 reference

based on heuristic

inferred from title

Serge Muyldermans

8

1 reference

Europe PubMed Central

10 September 2017

9

1 reference

Europe PubMed Central

10 September 2017

Catarina Xavier

3

object named as

Catarina Xavier

1 reference

Europe PubMed Central

10 September 2017

5

object named as

Ulrich Wernery

1 reference

Europe PubMed Central

10 September 2017

author name string

Jens De Vos

1

1 reference

Europe PubMed Central

10 September 2017

Iris Mathijs

2

1 reference

Europe PubMed Central

10 September 2017

Sam Massa

4

1 reference

Europe PubMed Central

10 September 2017

Luc Bouwens

6

1 reference

Europe PubMed Central

10 September 2017

Tony Lahoutte

7

1 reference

Europe PubMed Central

10 September 2017

publication date

1 October 2014

1 reference

Europe PubMed Central

10 September 2017

Molecular Imaging and Biology

1 reference

Europe PubMed Central

10 September 2017

16

1 reference

Europe PubMed Central

10 September 2017

5

1 reference

Europe PubMed Central

10 September 2017

690-698

1 reference

Europe PubMed Central

10 September 2017

https://scigraph.springernature.com/pub.10.1007/s11307-014-0731-6

0 references

Radionuclide imaging: a molecular key to the atherosclerotic plaque

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0731-6

21 January 2018

18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0731-6

21 January 2018

Imaging of the unstable plaque: how far have we got?

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0731-6

21 January 2018

The future of molecular imaging

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0731-6

21 January 2018

Detection of high-risk atherosclerotic plaque: report of the NHLBI Working Group on current status and future directions

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0731-6

21 January 2018

An endothelial receptor for oxidized low-density lipoprotein

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0731-6

21 January 2018

Expression of lectinlike oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0731-6

21 January 2018

Relationship between lectin-like oxidized low-density lipoprotein receptor 1 expression and preoperative echogenic findings of vulnerable carotid plaque.

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0731-6

21 January 2018

Cross-talk between dyslipidemia and renin-angiotensin system and the role of LOX-1 and MAPK in atherogenesis studies with the combined use of rosuvastatin and candesartan

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0731-6

21 January 2018

Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0731-6

21 January 2018

Overexpression of scavenger receptor LOX-1 in endothelial cells promotes atherogenesis in the ApoE(-/-) mouse model.

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0731-6

21 January 2018

Molecular imaging of atherosclerotic plaques targeted to oxidized LDL receptor LOX-1 by SPECT/CT and magnetic resonance

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0731-6

21 January 2018

Targeting of lectinlike oxidized low-density lipoprotein receptor 1 (LOX-1) with 99mTc-labeled anti-LOX-1 antibody: potential agent for imaging of vulnerable plaque

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0731-6

21 January 2018

Camelid single-domain antibody-fragment engineering for (pre)clinical in vivo molecular imaging applications: adjusting the bullet to its target

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0731-6

21 January 2018

Naturally occurring antibodies devoid of light chains

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0731-6

21 January 2018

Selection and identification of single domain antibody fragments from camel heavy-chain antibodies

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0731-6

21 January 2018

Molecular imaging using Nanobodies: a case study.

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0731-6

21 January 2018

Immuno-imaging using nanobodies

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0731-6

21 January 2018

Synthesis, preclinical validation, dosimetry, and toxicity of 68Ga-NOTA-anti-HER2 Nanobodies for iPET imaging of HER2 receptor expression in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0731-6

21 January 2018

Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT.

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0731-6

21 January 2018

Nanobody-coupled microbubbles as novel molecular tracer

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0731-6

21 January 2018

Nanobodies targeting mouse/human VCAM1 for the nuclear imaging of atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0731-6

21 January 2018

Beta-lactamase inhibitors derived from single-domain antibody fragments elicited in the camelidae

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0731-6

21 January 2018

In vitro analysis and in vivo tumor targeting of a humanized, grafted nanobody in mice using pinhole SPECT/micro-CT.

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0731-6

21 January 2018

Preclinical screening of anti-HER2 nanobodies for molecular imaging of breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0731-6

21 January 2018

LOX-1, OxLDL, and atherosclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0731-6

21 January 2018

Mast cell deficiency attenuates progression of atherosclerosis and hepatic steatosis in apolipoprotein E-null mice

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0731-6

21 January 2018

Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0731-6

21 January 2018

Nanobody-based targeting of the macrophage mannose receptor for effective in vivo imaging of tumor-associated macrophages.

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0731-6

21 January 2018

Localization, mechanism and reduction of renal retention of technetium-99m labeled epidermal growth factor receptor-specific nanobody in mice.

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0731-6

21 January 2018

Gene expression of LOX-1, VCAM-1, and ICAM-1 in pre-atherosclerotic mice

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0731-6

21 January 2018

Site-Specific Labeling of His-Tagged Nanobodies with 99mTc: A Practical Guide

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0731-6

21 January 2018

ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree

1 reference

https://pubmed.ncbi.nlm.nih.gov/24687730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lectin-like oxidized LDL receptor-1 (LOX-1) expression is associated with atherosclerotic plaque instability--analysis in hypercholesterolemic rabbits

1 reference

https://pubmed.ncbi.nlm.nih.gov/24687730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prominent lectin-like oxidized low density lipoprotein (LDL) receptor-1 (LOX-1) expression in atherosclerotic lesions is associated with tissue factor expression and apoptosis in hypercholesterolemic rabbits

1 reference

https://pubmed.ncbi.nlm.nih.gov/24687730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid visualization of human tumor xenografts through optical imaging with a near-infrared fluorescent anti-epidermal growth factor receptor nanobody.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24687730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo MRI detection of carotid atherosclerotic lesions and kidney inflammation in ApoE-deficient mice by using LOX-1 targeted iron nanoparticles

1 reference

https://pubmed.ncbi.nlm.nih.gov/24687730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oxidized low-density lipoprotein receptor LOX-1 and apoptosis in human atherosclerotic lesions

1 reference

https://pubmed.ncbi.nlm.nih.gov/24687730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11307-014-0731-6

1 reference

Europe PubMed Central

10 September 2017

release_3d3uq7kpdrhepigmudpd7tgtzu

0 references

1 reference

Europe PubMed Central

10 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39218666&oldid=1780886037"